与常规疗法相结合的海德拉素改善了严重的静脉缩功能障碍和 mitrale 吐的结果
Shih-Hung Hsiao1,2, Chao-Sheng Hsiao1,3, Jau-Wen Shiau4
1Division of Cardiology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
ESC heart failure
|October 28, 2023
概括
早期增加拉的标配量与基于证据的药物相结合,显著减少了患有严重缩功能障碍和心脏不全的患者的心血管死亡和心脏不全再住院.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有心力衰竭 (心力衰竭) 和左心室喷射率 (LVEF) 降低的患者具有显著的额叶回 (MR) 预后不佳.
- 之前的血管扩张试验在这个患者群体中产生了中性结果.
研究的目的:
- 为了研究在急性心力衰竭患者中与常规治疗一起提升得拉的早期定位的影响,这些患者呈现严重的缩功能障碍和显著的MR.
- 评估这种联合治疗方法的安全性和有效性.
主要方法:
- 一个开放的,随机的受控试验,比较常规治疗与拉加常规治疗.
- 包括患有失补偿性HF,LVEF<35%和中度至重度MR的患者.
- 主要终点是心血管死亡和HF再住院,平均随访时间为3.5年.
主要成果:
- 与传统治疗组 (n=203,51%) 相比,拉组 (n=205) 显示了复合心血管事件 (34.6%) 的显著减少 (危险比0.613,P < 0.001).
- 在指数入院期间的住院死亡率在拉组显着较低 (0.5%对5.4%,P = 0.001).
- 两组之间没有观察到基于证据的药物的处方率或剂量有显著差异,副作用也相似.
结论:
- 早期增加位的拉,当没有适当的预加载,改善了严重的缩功能障碍和显著的MR患者的结果.
- 这种组合治疗是安全的,耐受性很好,在这种高风险的HF人群中具有潜在的治疗益处.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
01:28Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40
01:25Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
01:20Mitral Regurgitation I: Introduction
15
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
15